Last reviewed · How we verify
Placebo for 5% Minoxidil Foam — Competitive Intelligence Brief
phase 3
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo for 5% Minoxidil Foam (Placebo for 5% Minoxidil Foam) — Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.. This is a placebo control formulation with no active pharmaceutical ingredient, used as a comparator in clinical trials for minoxidil foam efficacy.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo for 5% Minoxidil Foam TARGET | Placebo for 5% Minoxidil Foam | Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo for 5% Minoxidil Foam CI watch — RSS
- Placebo for 5% Minoxidil Foam CI watch — Atom
- Placebo for 5% Minoxidil Foam CI watch — JSON
- Placebo for 5% Minoxidil Foam alone — RSS
Cite this brief
Drug Landscape (2026). Placebo for 5% Minoxidil Foam — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-for-5-minoxidil-foam. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab